CervoMed Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
CervoMed Inc. (CRVO) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $57.52 million as of 2014-12-31, per its 10-K filed 2015-04-03.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2015-04-03
- 2014-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $57.52M.
- 2014-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $50.81M.
- 2014-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $53.56M.
- 2014-03-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $48.48M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2014-12-31 | $57.52M 10-K · filed 2015-04-03 |
| 2014-09-30 | $50.81M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $53.56M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $48.48M 10-Q · filed 2014-05-20 |
| 2013-12-31 | $47.73M 10-K · filed 2015-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |